Cardiovascular Surgery Unit, Santa Maria Hospital, Bari, Italy.
Eur J Cardiothorac Surg. 2012 Aug;42(2):242-7; discussion 247-8. doi: 10.1093/ejcts/ezr311. Epub 2012 Jan 30.
The late persistence of a patent and dilated false lumen into the thoracic aorta is associated to higher re-operation rates and to a worse prognosis after the surgical repair of De Bakey Type I acute aortic dissection (TIAAD). We present the mid-term results of a hybrid, two-stage technique for TIAAD aimed to reduce the risk of late expansion of the residual false lumen.
From May 2005 to January 2011, 49 patients with TIAAD were treated with the Lupiae technique. During the emergency operation, a Vascutek Lupiae™, a multi-branched Dacron prosthesis, was implanted to replace the ascending aorta, the aortic arch and to reroute the origin of the epiaortic vessels. The debranching of the aortic arch creates a long and stable Dacron landing zone on the ascending aorta suitable for further endovascular interventions. Postoperatively, 34 patients with a patent or partially thrombosed false lumen > 22 mm or a diameter of the descending aorta > 46 mm underwent the implant endovascular stentgrafts into the descending aorta.
Three patients died after the first procedure. One patient died after the endovascular stage. No patient experienced paraplegia or stroke. The 6-year follow-up survival was 90 ± 4%. The obliteration of the false lumen was obtained in 94% of the patients.
In patients with TIAAD, the debranching of the aortic arch with the Lupiae technique can be safely performed. This technique creates a long and stable landing zone that can be easily used for the deployment of endovascular stentgrafts in case of distal false lumen expansion.
假腔在胸主动脉内持续存在并扩张与更高的再手术率以及 De Bakey Ⅰ型急性主动脉夹层(TIAAD)手术后的预后较差相关。我们介绍一种杂交、两阶段技术治疗 TIAAD 的中期结果,旨在降低残余假腔晚期扩张的风险。
从 2005 年 5 月至 2011 年 1 月,49 例 TIAAD 患者接受了 Lupiae 技术治疗。在急诊手术中,植入了 Vascutek Lupiae™多分支涤纶假体,以替换升主动脉、主动脉弓并重新引导主动脉外膜血管的起源。主动脉弓的去分支化在升主动脉上形成了一个长而稳定的涤纶着陆区,适合进一步的血管内介入治疗。术后,34 例假腔>22mm 或降主动脉直径>46mm 的患者行降主动脉腔内支架移植术。
3 例患者在第一次手术后死亡。1 例患者在血管内阶段死亡。无患者发生截瘫或中风。6 年随访生存率为 90±4%。94%的患者假腔闭塞。
在 TIAAD 患者中,使用 Lupiae 技术进行主动脉弓去分支化是安全的。该技术形成了一个长而稳定的着陆区,在远端假腔扩张时可方便地用于部署血管内支架。